Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Leukemia. 2013 Jul 1;27(12):2272–2279. doi: 10.1038/leu.2013.197

Figure 5. TG101209 prolongs lifespan of secondary transplanted AE9a leukemia mice.

Figure 5

Survival curves of MF-1 mice transplanted with 1 × 105 EGFP+ leukemia cells from primary transplanted AE9a leukemia mice. Three weeks after secondary transplantation, mice were treated with placebo (n = 8) or TG101209 (100 mg/kg) (n = 9) twice daily for 5 days and then once daily for 9 days. The p value was determined by using the Log-rank test.